New registry aims to sharpen use of precision radiation in advanced cancer
NCT ID NCT02170181
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 31 times
Summary
This study created a registry of 149 cancer patients who received a precise type of radiation called SBRT. The goal was to track how doctors use SBRT in four situations: for cancer that has spread to a few spots, after chemotherapy, before starting chemotherapy, or when cancer returns in a previously treated area. By collecting this information, researchers hope to learn which patients benefit most and improve future treatment guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75239, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Stereotactic body radiation therapy (SBRT)
What this could lead to
If successful, this registry could help doctors better understand when and how to use SBRT for cancer that has spread, potentially improving treatment decisions.
What could go wrong
This is an observational registry, not a treatment trial, so it won't directly test if SBRT works better than other options. Results may not apply to all cancer types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.